Cargando…
Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease
BACKGROUND: Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine. Chronic inflammation induced by amyloid β proteins (Aβ) is one prominent neuropathological feature in Alzheimer’s disease (AD) brain. METHODS: Elisa, Western blot, and immunohistochemical staining analysis were...
Autores principales: | Zhang, Si, Zhao, Jiehao, Zhang, Yuhu, Zhang, Yun, Cai, Fang, Wang, Lijuan, Song, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555932/ https://www.ncbi.nlm.nih.gov/pubmed/31174614 http://dx.doi.org/10.1186/s13195-019-0508-x |
Ejemplares similares
-
Isopsoralen ameliorates rheumatoid arthritis by targeting MIF
por: Han, Yi, et al.
Publicado: (2021) -
MECHANISM OF ACTION OF MIGRATION INHIBITORY FACTOR (MIF) : I. EVIDENCE FOR A RECEPTOR FOR MIF PRESENT ON THE PERITONEAL MACROPHAGE BUT NOT ON THE ALVEOLAR MACROPHAGE
por: Leu, Richard W., et al.
Publicado: (1972) -
Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo
por: Zhang, Mingming, et al.
Publicado: (2014) -
4‐Iodopyrimidine Labeling Reveals Nuclear Translocation and Nuclease Activity for Both MIF and MIF2
por: Xiao, Zhangping, et al.
Publicado: (2021) -
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
por: Nasiri, Elham, et al.
Publicado: (2020)